These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17650517)

  • 21. Perioperative handling of patients on antiplatelet therapy with need for surgery.
    Di Minno MN; Prisco D; Ruocco AL; Mastronardi P; Massa S; Di Minno G
    Intern Emerg Med; 2009 Aug; 4(4):279-88. PubMed ID: 19533288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.
    Finkel JB; Marhefka GD; Weitz HH
    Hosp Pract (1995); 2013 Feb; 41(1):79-88. PubMed ID: 23466970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative management of dual anti-platelet therapy.
    Webster TD; Vaishnava P; Eagle KA
    Hosp Pract (1995); 2016 Dec; 44(5):237-241. PubMed ID: 27846735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital.
    Fujikawa T; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N
    J Am Coll Surg; 2013 Dec; 217(6):1044-53. PubMed ID: 24051069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant differences between vascular and nonvascular surgeons in the perioperative management of antiplatelet therapies in patients with coronary stents.
    Kilic A; Sultan IS; Arnaoutakis GJ; Black JH; Reifsnyder T
    Ann Vasc Surg; 2015 Apr; 29(3):526-33.e2. PubMed ID: 25476748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative handling of antiplatelet drugs. A critical appraisal.
    Di Minno MN; Milone M; Mastronardi P; Ambrosino P; Di Minno A; Parolari A; Tremoli E; Prisco D
    Curr Drug Targets; 2013 Jul; 14(8):880-8. PubMed ID: 23627916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative use of anti-platelet drugs.
    Chassot PG; Delabays A; Spahn DR
    Best Pract Res Clin Anaesthesiol; 2007 Jun; 21(2):241-56. PubMed ID: 17650775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
    Rossini R; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Musumeci G; Visconti LO; Piccaluga E; Savonitto S; Trabattoni D; Buffoli F; Angiolillo DJ; Bovenzi F; Cremonesi A; Scherillo M; Guagliumi G; ;
    G Ital Cardiol (Rome); 2012; 13(7-8):528-51. PubMed ID: 22781382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.
    Hermiller JB; Krucoff MW; Kereiakes DJ; Windecker S; Steg PG; Yeh RW; Cohen DJ; Cutlip DE; Massaro JM; Hsieh WH; Mauri L;
    JACC Cardiovasc Interv; 2016 Jan; 9(2):138-47. PubMed ID: 26793956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative management of patients with coronary stents in non-cardiac surgery].
    Jámbor C; Spannagl M; Zwissler B
    Anaesthesist; 2009 Oct; 58(10):971-85. PubMed ID: 19823781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary stents: factors contributing to perioperative major adverse cardiovascular events.
    Barash P; Akhtar S
    Br J Anaesth; 2010 Dec; 105 Suppl 1():i3-15. PubMed ID: 21148653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute myocardial infarction after discontinuing aspirin two years after implantation of a drug-eluting coronary stent].
    Krüth P; Heer T; Senges J; Zeymer U
    Dtsch Med Wochenschr; 2007 Feb; 132(5):201-4. PubMed ID: 17252362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery.
    Möllmann H; Nef HM; Hamm CW; Elsässer A
    Clin Res Cardiol; 2009 Jan; 98(1):8-15. PubMed ID: 18853094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late and very late drug-eluting stent thrombosis in the immediate postoperative period after antiplatelet withdrawal: a retrospective study.
    Omar HR; Sprenker C; Karlnoski R; Camporesi EM; Mangar D
    Ther Adv Cardiovasc Dis; 2014 Oct; 8(5):185-92. PubMed ID: 25015068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
    Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.